Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder

Background This study assessed treatment satisfaction of cystic fibrosis (CF) patients in a routine clinical setting for tobramycin inhalation powder (TIP), the first dry powder–inhaled antibiotic for Pseudomonas aeruginosa infection.